Ezra is a healthcare technology company dedicated to providing early cancer detection for everyone by combining the most advanced medical imaging technology and Artificial Intelligence.

Ezra utilizes medical imaging and Artificial Intelligence to provide individuals with full-body cancer screening that is fast, accurate, and affordable.

Ezra was founded in 2018 by Emi Gal and Diego Cantor. The company is headquartered in New York, New York.

Ezra's goal is to offer a whole-body MRI scan in a single session and analyze it using the Ezra AI to quickly and accurately diagnose potential abnormalities anywhere in the body.

Ezra is improving early cancer detection through its proprietary full-body MRI scan that takes under an hour and screens for cancer in up to 12 organs. The company is also developing Artificial Intelligence designed to decrease the cost of MRI-based cancer screening. The first Ezra AI, created to assist radiologists in their analysis of prostate MRI scans, is currently under FDA review.


Ezra launched its MRI-based prostate cancer screening program in January 2019, and rolled out its full-body MRI scan in May 2019. Ezra partners with existing outpatient imaging facilities, and all Ezra scans are analyzed by board-certified radiologists.


Ezra is backed by FirstMark Capital, Accomplice, Seedcamp, Credo Ventures, Founders Future, Jeff Raider and Dave Gilboa (co-founders of Harry's and Warby Parker), Vlad Tenev (co-founder of Robinhood) and others. The company raised $18M in Series A round on June 01, 2020. This brings Ezra's total funding to $22M to date.



  • Year founded: 2018
  • Funding Info: $22M over 2 Rounds (Latest Funding Type: Series A)
  • Yearly Revenue: NA
  • Employee Size: 11-50
  • Business Valuation: NA
  • City/Town: New York
  • State: New York
  • Country: United States
Related businesses